Response to "Does amantadine have a protective effect against COVID-19?"

Tipton, Philip W; Wszolek, Zbigniew K

Tipton, Philip W; Wszolek, Zbigniew K.

Tipton PW; Department of Neurology, Mayo Clinic Florida, Jacksonville, USA. tipton.philip@mayo.edu.
Wszolek ZK; Department of Neurology, Mayo Clinic Florida, Jacksonville, USA.

Neurol Neurochir Pol ; 54(3): 286-287, 2020.

Article in English | MEDLINE | ID: covidwho-616663

Subject(s)

Coronavirus Infections; Pandemics; Pneumonia, Viral; Amantadine; Betacoronavirus; COVID-19; Humans; SARS-CoV-2

Keywords

COVID-19; Parkinson's disease; amantadine; memantine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics Type of study: Experimental Studies Limits: Humans Language: English Journal: Neurol Neurochir Pol Year: 2020 Document Type: Article Affiliation country: PJNNS.a2020.0048

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google